Related Experiment Video

Updated: Jun 9, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

The use of human tissue in drug discovery

Iain G Dougall1

  • 1AstraZeneca R&D Charnwood, Bioscience Department, Bakewell Road, Loughborough, Leicestershire, UK. Iain.Dougall@astrazeneca.com

Cell and Tissue Banking
|September 9, 2010
PubMed

Insights

Human tissue samples are vital for drug discovery, aiding in understanding diseases and identifying safe, effective drug targets. Improved access to these tissues will accelerate the development of new medicines.

Area of Science:

  • Pharmacology
  • Biomedical Research
  • Drug Discovery

Background:

  • Human tissue samples are essential in drug discovery, complementing animal-based assays.
  • These studies enhance understanding of disease pathophysiology and target validation.
  • They inform therapeutic potential and safety profiles of drug targets.

Purpose of the Study:

  • To highlight the critical role of human tissue samples in modern drug discovery.
  • To emphasize the value of human tissue in identifying efficacious and safe medicines.
  • To advocate for improved access to human tissue for research.

Main Methods:

  • Utilizing human tissue samples in various drug discovery stages.
  • Incorporating human tissues into screening cascades and high-throughput assays.
  • Leveraging new technologies for tissue-based research.

Main Results:

  • Human tissue studies improve understanding of disease mechanisms.
  • They provide crucial data for validating molecular targets for therapeutic intervention.
  • Tissue analysis informs potential safety risks associated with drug targets.

Conclusions:

  • Human tissue experiments are indispensable for identifying viable drug targets.
  • Enhanced access to human tissues can significantly advance drug discovery pipelines.
  • Tissue-based research is key to addressing unmet clinical needs with novel therapeutics.

More Related Videos

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

An All-Human Hepatic Culture System for Drug Development Applications07:23

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...